US5306825AExpiredUtility

Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process

Assignee: CONSIGLIO NAZIONALE RICERCHEPriority: Mar 1, 1984Filed: Apr 26, 1989Granted: Apr 26, 1994
Est. expiryMar 1, 2004(expired)· nominal 20-yr term from priority
C07D 487/04
58
PatentIndex Score
6
Cited by
26
References
3
Claims

Abstract

Physostigmine derivatives with acetylcholinesterase inhibition properties, of general formula: ##STR1## in which R is a linear alkyl of from 2 to 20 C. atoms, a branched alkyl, a cycloalkyl or an aryl, when R' is H, or R and R' are linear alkyl of from 2 to 20 C. atoms.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A process for preparing physostigmine derivatives with acetylcholinesterase inhibition properties, of the following formula: ##STR6## in which R is selected from the group consisting of propyl, isopropyl, tert-butyl, phenyl, cyclohexyl, heptyl, undecyl and pentadecyl when R' is H or R and R' are both ethyl or methyl, in accordance with the following schemes: ##STR7## wherein X is methyl. 
     
     
       2. A process for preparing physostigmine derivatives as claimed in claim 1, in which the alkyl alcohol is ethanol and the medium-polar hydrocarbon solvent is benzene. 
     
     
       3. A process for preparing physostigmine derivatives as claimed in claim 1, characterised in that the reaction is carried out under vacuum.

Join the waitlist — get patent alerts

Track US5306825A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.